| Systematic (IUPAC) name | |
|---|---|
| (6,6,9-trimethyl-3-(3-methyloctan-2-yl)-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl)-4-(azepan-1-yl)butanoate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 58019-65-1 |
| ATC code | ? |
| PubChem | CID 163326 |
| UNII | N1RX70K36C |
| Chemical data | |
| Formula | C35H55NO3 |
| Mol. mass | 537.814 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
Nabazenil (SP-175) is a synthetic cannabinoid receptor agonist, which has anticonvulsant properties.[1]
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)